Reports


Bile Duct Cancer Drug Market by Type (5-fluorouracil (5-FU), Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, and Others) and by Application (Hospitals, Clinics, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2017—2024

  • TBI288330
  • October 19, 2020
  • Global
  • 132 pages
  • SAC Insights
                                              Abstract

The report covers a forecast and an analysis of the bile duct cancer drug market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD million). The study includes drivers and restraints for the bile duct cancer drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the bile duct cancer drug market on a global level.

In order to give the users of this report a comprehensive view of the bile duct cancer drug market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view on the bile duct cancer drug market by segmenting the market based on type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.

By type, bile duct cancer drug market is segmented as 5-fluorouracil (5-FU), capecitabine, gemcitabine, oxaliplatin, cisplatin, and other. Based on application, bile duct cancer drug market has been segmented into hospitals, clinics, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, Italy, France, UK, China, Japan, India, and Brazil.

Some key players of the bile duct cancer drug market include Delcath Systems Inc., Accord Healthcare, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly and Company, Mylan N.V, Fresenius Kabi AG, Intercept Pharmaceuticals, Inc., and Celgene Corporation, among others.

This report segments the global bile duct cancer drug market into:

Global Bile Duct Cancer Drug Market: By Product
  • 5-fluorouracil (5-FU)
  • Gemcitabine (Gemcitabine Injection (the generic equivalent of Eli Lilly's, Gemzar®), available in 200mg/5.26mL, 1G/26.3mL and 2G/52.6mL; has an approximate market size of $25M, annually.)
  • Cisplatin
  • Capecitabine
  • Oxaliplatin
  • Others
Global Bile Duct Cancer Drug Market: By Application
  • Hospitals
  • Clinics
  • Others
Global Bile Duct Cancer Drug Market: By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Table of Contents
                    
                    
                         Request Table Of Content
                         Click To Request Sample
                    

	Chapter 1. Introduction
	
		1.1. Report description and scope
		1.2. Research scope
		1.3. Research methodology
		
			1.3.1. Market research process
			1.3.2. Market research methodology
		
		
	
	
	 
	Chapter 2. Executive Summary
	
		2.1. Global Bile Duct Cancer Drug Market, 2017 - 2024 (USD Million)
		2.2. Global Bile Duct Cancer Drug Market: Snapshot
	
	
	 
	Chapt
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form